{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:06:33Z","timestamp":1793815593582,"version":"4.6.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jad.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T11:29:09Z","timestamp":1592911749000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The association of HTR2A polymorphisms with obsessive-compulsive disorder and its subtypes: A meta-analysis"],"prefix":"10.1016","volume":"275","author":[{"given":"Gabriella Francesca","family":"Mattina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.06.016_bib0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive-compulsive disorder","volume":"374","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2020.06.016_bib0002","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1093\/bioinformatics\/btq538","article-title":"DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks","volume":"26","author":"Bauer-Mehren","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jad.2020.06.016_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(96)12307-7","article-title":"Sex difference in 5HT2 receptor in the living human brain","volume":"204","author":"Biver","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2020.06.016_bib0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/01677063.2017.1336236","article-title":"Obsessive\u2013compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology","volume":"31","author":"Bozorgmehr","year":"2017","journal-title":"J. Neurogenet"},{"key":"10.1016\/j.jad.2020.06.016_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.mp.4001366","article-title":"The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain","volume":"9","author":"Bray","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The Combination of Estimates from Different Experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2020.06.016_bib0007","doi-asserted-by":"crossref","first-page":"335","DOI":"10.6061\/clinics\/2012(04)06","article-title":"Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder","volume":"67","author":"Corregiari","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.jad.2020.06.016_bib0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500342","article-title":"Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies","volume":"6","author":"Davies","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jad.2020.06.016_bib0009","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/S1516-44462011000400014","article-title":"Gender differences in obsessive-compulsive disorder: a literature review","volume":"33","author":"de Mathis","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jad.2020.06.016_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eurpsy.2008.01.002","article-title":"Obsessive\u2013compulsive disorder: Influence of age at onset on comorbidity patterns","volume":"23","author":"de Mathis","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2005.12.011","article-title":"Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder","volume":"91","author":"Denys","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.06.016_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2020.06.016_bib0013","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biopsych.2006.09.030","article-title":"Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder","volume":"61","author":"Dickel","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0014","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1176\/ajp.154.4.582a","article-title":"Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline","volume":"154","author":"Dodt","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S1461145712000740","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"16","author":"Dold","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.016_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2020.06.016_bib0017","first-page":"89","article-title":"A nonparametric \u201cTrim and Fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval","year":"2000","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.jad.2020.06.016_bib0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0006-3223(00)01040-4","article-title":"Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder","volume":"49","author":"Enoch","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0019","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(05)78746-8","article-title":"5-HT2A promoter polymorphism -1438G\/A, anorexia nervosa, and obsessive-compulsive disorder","volume":"351","author":"Enoch","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2020.06.016_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euroneuro.2004.04.004","article-title":"Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"15","author":"Erzegovesi","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.016_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12017-010-8138-2","article-title":"Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association","volume":"13","author":"Falkenberg","year":"2011","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.jad.2020.06.016_bib0022","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2020.06.016_bib0023","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11920-014-0510-8","article-title":"Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature","volume":"16","author":"Fonseka","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2020.06.016_bib0024","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pnpbp.2005.11.001","article-title":"The descriptive epidemiology of obsessive-compulsive disorder","volume":"30","author":"Fontenelle","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4088\/JCP.09m05381blu","article-title":"Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period","volume":"71","author":"Forray","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0924-977X(00)00071-7","article-title":"Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways","volume":"10","author":"Frisch","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.016_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2017.12.004","article-title":"Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism","volume":"82","author":"Gomes","year":"2018","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0028","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1176\/ajp.2006.163.11.1986","article-title":"Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects","volume":"163","author":"Grabe","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0029","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.psychres.2017.10.047","article-title":"Genetic analysis of impulsive personality traits: Examination of a priori candidates and genome-wide variation","volume":"259","author":"Gray","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jad.2020.06.016_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1521-4036(199912)41:8<901::AID-BIMJ901>3.0.CO;2-W","article-title":"An alternative method for meta-analysis","volume":"41","author":"Hartung","year":"1999","journal-title":"Biometrical J."},{"key":"10.1016\/j.jad.2020.06.016_bib0031","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/sim.791","article-title":"On tests of the overall treatment effect in meta-analysis with normally distributed responses","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0032","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0033","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/sim.791","article-title":"On tests of the overall treatment eeect in meta-analysis with normally distributed responses","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat. Med. Stat. Med"},{"key":"10.1016\/j.jad.2020.06.016_bib0034","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1081\/SAC-120023884","article-title":"Reducing the Number of Unjustified Significant Results in Meta-analysis","volume":"32","author":"Hartung","year":"2003","journal-title":"Commun. Stat. - Simul. Comput."},{"key":"10.1016\/j.jad.2020.06.016_bib0035","series-title":"Investigating the Molecular Aetiology of Obsessive-compulsive disorder (OCD) and Clinically-defined Subsets of OCD","author":"Hemmings","year":"2006"},{"key":"10.1016\/j.jad.2020.06.016_bib0036","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0037","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2020.06.016_bib0038","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S1461145703003730","article-title":"Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study","volume":"6","author":"Hollander","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.06.016_bib0039","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.158.1.147-a","article-title":"Levels of serotonin receptor 2A higher in suicide victims?","volume":"158","author":"Hrdina","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jad.2020.06.016_bib0041","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/sim.7411","article-title":"The Hartung-Knapp modification for random-effects meta-analysis: a useful refinement but are there any residual concerns?","volume":"36","author":"Jackson","year":"2017","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0042","article-title":"No associations between 5-HTT, 5-HT2A gene polymorphisms and obsessive-compulsive disorder in a Korean population","author":"Jung","year":"2006","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2020.06.016_bib0043","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0140-6736(05)61695-9","article-title":"5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia","volume":"349","author":"Kouzmenko","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2020.06.016_bib0044","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000022853","article-title":"No Correlation between A(\u20131438)G Polymorphism in 5-HT2A Receptor Gene Promoter and the Density of Frontal Cortical 5-HT2A Receptors in Schizophrenia","volume":"49","author":"Kouzmenko","year":"1999","journal-title":"Hum. Hered."},{"key":"10.1016\/j.jad.2020.06.016_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2012.10.006","article-title":"Quality of life in obsessive-compulsive disorder: the role of mediating variables","volume":"206","author":"Kugler","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jad.2020.06.016_bib0046","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.psychres.2010.08.030","article-title":"Association analysis of serotonin and catecholamine system candidate genes in obsessive-compulsive disorder in the Chinese population","volume":"188","author":"Liu","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.06.016_bib0047","first-page":"1112","article-title":"Association of 5-HTR2A gene -1438G\/A polymorphisms with obsessive-compulsive disorder and efficacy of sertraline treatment","volume":"33","author":"Liu","year":"2013","journal-title":"J. Shanghai Jiaotong Univ. Med. Sci."},{"key":"10.1016\/j.jad.2020.06.016_bib0048","first-page":"164","article-title":"Cluster analysis of obsessive-compulsive symptomatology: Identifying obsessive-compulsive disorder subtypes","volume":"45","author":"Lochner","year":"2008","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.jad.2020.06.016_bib0049","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00737-015-0526-z","article-title":"Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis","volume":"18","author":"Mak","year":"2015","journal-title":"Arch. Womens. Ment. Health"},{"key":"10.1016\/j.jad.2020.06.016_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/BIP-120037191","article-title":"The effect of the heterogeneity variance estimator on some tests of treatment efficacy","volume":"14","author":"Makambi","year":"2004","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.jad.2020.06.016_bib0051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/gbb.12128","article-title":"Role of GAD2 and HTR1B genes in early-onset obsessive-compulsive disorder: Results from transmission disequilibrium study","volume":"13","author":"Mas","year":"2014","journal-title":"Genes, Brain Behav."},{"key":"10.1016\/j.jad.2020.06.016_bib0052","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2016.01.012","article-title":"The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: overview","volume":"67","author":"Mattina","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0053","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cpr.2004.04.003","article-title":"A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms","volume":"24","author":"McKay","year":"2004","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2020.06.016_bib0054","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1601-1848.2003.0042.x","article-title":"Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder","volume":"3","author":"Meira-Lima","year":"2004","journal-title":"Genes, Brain Behav."},{"key":"10.1016\/j.jad.2020.06.016_bib0055","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0006-3223(00)00967-7","article-title":"Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study","volume":"48","author":"Moses","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0056","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopsych.2005.12.018","article-title":"Polymorphisms in the regulatory region of the human serotonin 5-HT 2A receptor gene (HTR2A) influence gene expression","volume":"61","author":"Myers","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0057","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psc.2009.11.001","article-title":"Genetics of obsessive-compulsive disorder","volume":"33","author":"Nestadt","year":"2010","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2020.06.016_bib0058","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archpsyc.57.4.358","article-title":"A family study of obsessive-compulsive disorder","volume":"57","author":"Nestadt","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0059","first-page":"461","article-title":"DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder","volume":"1","author":"Nicolini","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/07853890510037347","article-title":"HTR2A: association and expression studies in neuropsychiatric genetics","volume":"37","author":"Norton","year":"2005","journal-title":"Ann. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0061","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.06.020","article-title":"The -1438A\/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity","volume":"56","author":"Parsons","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.jad.2020.06.016_bib0062","first-page":"30","article-title":"Recent findings in the genetics of OCD","volume":"63","author":"Pato","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0063","doi-asserted-by":"crossref","first-page":"149","DOI":"10.31887\/DCNS.2010.12.2\/dpauls","article-title":"The genetics of obsessive-compulsive disorder: a review","volume":"12","author":"Pauls","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2020.06.016_bib0064","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2020.06.016_bib0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11920-017-0847-x","article-title":"The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders","volume":"19","author":"Pignon","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2020.06.016_bib0066","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jnr.20732","article-title":"Allele C-specific methylation of the 5-HT2A receptor gene: Evidence for correlation with its expression and expression of DNA methylase DNMT1","volume":"83","author":"Polesskaya","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jad.2020.06.016_bib0067","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/jnr.10173","article-title":"Differential expression of the &quot;C&quot; and &quot;T&quot; alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics","volume":"67","author":"Polesskaya","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jad.2020.06.016_bib0068","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00002826-199619040-00003","article-title":"Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients","volume":"19","author":"Poyurovsky","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2020.06.016_bib0069","doi-asserted-by":"crossref","first-page":"bav069","DOI":"10.1093\/database\/bav069","article-title":"OCDB: a database collecting genes, miRNAs and drugs for obsessive-compulsive disorder","volume":"2015","author":"Privitera","year":"2015","journal-title":"Database"},{"key":"10.1016\/j.jad.2020.06.016_bib0070","series-title":"R: A Language and Environment for Statistical Computing, https:\/\/www.r-project.org","author":"Core Team","year":"2019"},{"key":"10.1016\/j.jad.2020.06.016_bib0071","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.psychres.2017.10.038","article-title":"Examining the role of sex differences in obsessive-compulsive symptom dimensions","volume":"259","author":"Raines","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.06.016_bib0072","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jrsm.1312","article-title":"Estimation of an overall standardized mean difference in random-effects meta-analysis if the distribution of random effects departs from normal","volume":"9","author":"Rubio-Aparicio","year":"2018","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jad.2020.06.016_bib0073","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12863-015-0325-6","article-title":"Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons","volume":"17","author":"Ruble","year":"2016","journal-title":"BMC Genet."},{"key":"10.1016\/j.jad.2020.06.016_bib0074","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4088\/JCP.12r07917","article-title":"Risk of obsessive-compulsive disorder in pregnant and postpartum women","volume":"74","author":"Russell","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0076","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.pnpbp.2007.12.005","article-title":"Association study between obsessive-compulsive disorder and serotonergic candidate genes","volume":"32","author":"Saiz","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0077","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4000842","article-title":"Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia","volume":"6","author":"Segman","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0078","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12874-018-0618-3","article-title":"Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies","volume":"19","author":"Seide","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jad.2020.06.016_bib0079","doi-asserted-by":"crossref","first-page":"e15987","DOI":"10.1097\/MD.0000000000015987","article-title":"The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jad.2020.06.016_bib0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1081\/SAC-120023885","article-title":"On constructing confidence intervals for a standardized mean difference in meta-analysis","volume":"32","author":"Sidik","year":"2003","journal-title":"Commun. Stat. - Simul. Comput."},{"key":"10.1016\/j.jad.2020.06.016_bib0081","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/sim.1262","article-title":"A simple confidence interval for meta-analysis","volume":"21","author":"Sidik","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0082","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/NDT.S163946","article-title":"Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in iranian patients: a genetic and pharmacogenetic study","volume":"14","author":"Sina","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2020.06.016_bib0083","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2017.05.029","article-title":"A review of the role of serotonin system genes in obsessive-compulsive disorder","volume":"80","author":"Sinopoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2020.06.016_bib0084","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.psyneuen.2007.11.001","article-title":"Genetic evaluation of the serotonergic system in chronic fatigue syndrome","volume":"33","author":"Smith","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2020.06.016_bib0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2012.09.028","article-title":"Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex","volume":"73","author":"Smith","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0086","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","article-title":"Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool","volume":"16","author":"Sohani","year":"2015","journal-title":"BMC Genet."},{"key":"10.1016\/j.jad.2020.06.016_bib0087","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.mp.4000342","article-title":"A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter","volume":"3","author":"Spurlock","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0088","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.b.32407","article-title":"Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis","volume":"171","author":"Taylor","year":"2016","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.jad.2020.06.016_bib0089","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/mp.2012.76","article-title":"Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0090","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cpr.2011.09.008","article-title":"Etiology of obsessions and compulsions: a meta-analysis and narrative review of twin studies","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2020.06.016_bib0091","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2020.06.016_bib0092","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jrsm.53","article-title":"Comparison of statistical inferences from the DerSimonian-Laird and alternative random-effects model meta-analyses - an empirical assessment of 920 Cochrane primary outcome meta-analyses","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.jad.2020.06.016_bib0093","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0924-9338(03)00066-X","article-title":"T102C and -1438 G\/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder","volume":"18","author":"Tot","year":"2003","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0094","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1176\/ajp.156.9.1456","article-title":"Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide","volume":"156","author":"Turecki","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0095","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1017\/S0033291707000980","article-title":"Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study","volume":"37","author":"Van Grootheest","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.06.016_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2020.06.016_bib0097","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00702-011-0699-1","article-title":"Pilot study on HTR2A promoter polymorphism, -1438G\/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder","volume":"119","author":"Walitza","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jad.2020.06.016_bib0098","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.mp.4001105","article-title":"5-HT2A promoter polymorphism -1438G\/A in children and adolescents with obsessive-compulsive disorders","volume":"7","author":"Walitza","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.06.016_bib0099","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1523\/JNEUROSCI.15-07-04885.1995","article-title":"Characterization of the human 5-HT2A receptor gene promoter","volume":"15","author":"Zhu","year":"1995","journal-title":"J. Neurosci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720323740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720323740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:43:30Z","timestamp":1759023810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720323740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":99,"alternative-id":["S0165032720323740"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.06.016","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of HTR2A polymorphisms with obsessive-compulsive disorder and its subtypes: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}